Royce & Associates’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,769	Closed	-$380K	–	892
2023 Q4	$380K	Buy	+18,769	New	+$380K	﹤0.01%	807
2022 Q1	–	Sell	-9,300	Closed	-$204K	–	981
2021 Q4	$204K	Buy	+9,300	New	+$204K	﹤0.01%	945